Prophylactic Intraoperative Uterine Artery Embolization During Cesarean Section or Cesarean Hysterectomy in Patients with Abnormal Placentation: A Systematic Review and Meta-Analysis
- PMID: 34282489
- DOI: 10.1007/s00270-021-02921-2
Prophylactic Intraoperative Uterine Artery Embolization During Cesarean Section or Cesarean Hysterectomy in Patients with Abnormal Placentation: A Systematic Review and Meta-Analysis
Abstract
Purpose: To evaluate the effectiveness and safety of prophylactic intraoperative uterine artery embolization (UAE) performed immediately after fetal delivery during planned cesarean section or cesarean hysterectomy in patients with placenta accreta spectrum disorder or placenta previa.
Methods: A systematic search was conducted on Ovid MEDLINE and Embase, PubMed, Web of Science, and Cochrane databases. Studies were selected using the Population/Intervention/Comparison/Outcomes (PICO) strategy. The intraoperative blood loss and the rate of emergent peripartum hysterectomy (EPH) were the primary outcomes, whereas the length of hospital stay and volume of blood transfused were the secondary outcomes. A random-effects model was employed to pool each effect size. The cumulative values of the primary outcomes were calculated using the generic inverse variance method.
Results: Eleven retrospective cohort studies and five case series were included, recruiting 421 women who underwent prophylactic intraoperative UAE (UAE group) and 374 women who did not (control group). Compared with the control group, the UAE group had significantly reduced intraoperative blood loss (p = 0.020) during cesarean section or cesarean hysterectomy. Furthermore, the EPH rate was also significantly decreased (p = 0.020; cumulative rate: 19.65%), but not the length of hospital stay (p = 0.850) and volume of pRBC transfused (p = 0.140), after cesarean section in the UAE group. The incidence of major complications was low (3.33%), despite two patients with uterine necrosis.
Conclusion: The currently available data provides encouraging evidence that prophylactic intraoperative UAE may contribute to hemorrhage control and fertility preservation in women with abnormal placentation.
Registration: PROSPERO registration code: CRD42021230581. https://clinicaltrials.gov/ct2/show/CRD42021230581 LEVEL OF EVIDENCE: Level 2a, systematic review of retrospective cohort studies.
Keywords: Endovascular procedures; Placenta accreta; Placenta diseases; Placenta previa; Postpartum hemorrhage; Transarterial embolization.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Similar articles
-
Prophylactic uterine artery embolization during cesarean delivery for placenta previa complicated by placenta accreta.Int J Gynaecol Obstet. 2020 Apr;149(1):43-47. doi: 10.1002/ijgo.13072. Epub 2019 Dec 20. Int J Gynaecol Obstet. 2020. PMID: 31778209
-
Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta.Int J Gynaecol Obstet. 2017 Apr;137(1):45-50. doi: 10.1002/ijgo.12090. Epub 2017 Jan 18. Int J Gynaecol Obstet. 2017. PMID: 28098341
-
Every minute counts: a network meta-analysis comparing the effect of prophylactic endovascular procedures in abnormal placentation.World J Emerg Surg. 2025 May 24;20(1):43. doi: 10.1186/s13017-025-00602-w. World J Emerg Surg. 2025. PMID: 40413552 Free PMC article.
-
Clinical evaluation of the effect for prophylactic balloon occlusion in pregnancies complicated with placenta accreta spectrum disorder: A systematic review and meta-analysis.Int J Gynaecol Obstet. 2024 Oct;167(1):109-127. doi: 10.1002/ijgo.15704. Epub 2024 Jun 20. Int J Gynaecol Obstet. 2024. PMID: 38899567
-
Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis.Obstet Gynecol. 2022 Oct 1;140(4):599-606. doi: 10.1097/AOG.0000000000004923. Epub 2022 Sep 7. Obstet Gynecol. 2022. PMID: 36075058
Cited by
-
Prophylactic occlusion balloon in placenta abnormalities: What every interventional radiologist needs to know.World J Radiol. 2025 Jul 28;17(7):107737. doi: 10.4329/wjr.v17.i7.107737. World J Radiol. 2025. PMID: 40746523 Free PMC article. Review.
-
Management and Outcome of Women with Placenta Accreta Spectrum and Treatment with Uterine Artery Embolization.J Clin Med. 2024 Feb 13;13(4):1062. doi: 10.3390/jcm13041062. J Clin Med. 2024. PMID: 38398377 Free PMC article.
-
Comparison of One-Stage and Two-Stage Intraoperative Uterine Artery Embolization during Cesarean Delivery for Placenta Accreta: Report of Two Clinical Cases at a Tertiary Referral Medical Center.Healthcare (Basel). 2022 Apr 22;10(5):774. doi: 10.3390/healthcare10050774. Healthcare (Basel). 2022. PMID: 35627911 Free PMC article.
-
The role of interventional radiology in managing placenta accreta spectrum.BJA Educ. 2025 Apr;25(4):163-170. doi: 10.1016/j.bjae.2024.11.005. Epub 2025 Jan 27. BJA Educ. 2025. PMID: 40161486 Review. No abstract available.
-
Using Deep Learning to Predict Treatment Response in Patients with Hepatocellular Carcinoma Treated with Y90 Radiation Segmentectomy.J Digit Imaging. 2023 Jun;36(3):1180-1188. doi: 10.1007/s10278-022-00762-0. Epub 2023 Jan 11. J Digit Imaging. 2023. PMID: 36629989 Free PMC article.
References
-
- Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378:1529–36. - PubMed
-
- Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219:B2–16. - PubMed
-
- Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accrete diagnosis and management: Green-top guideline No. 27a. BJOG Int J Obstet Gy. 2019;126:e1–48.
-
- Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75–87. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous